EP0327519B1 - An appliance for the mixing and/or transfer of a substance - Google Patents

An appliance for the mixing and/or transfer of a substance Download PDF

Info

Publication number
EP0327519B1
EP0327519B1 EP19890850025 EP89850025A EP0327519B1 EP 0327519 B1 EP0327519 B1 EP 0327519B1 EP 19890850025 EP19890850025 EP 19890850025 EP 89850025 A EP89850025 A EP 89850025A EP 0327519 B1 EP0327519 B1 EP 0327519B1
Authority
EP
European Patent Office
Prior art keywords
connection
unit
aperture
appliance
duct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP19890850025
Other languages
German (de)
French (fr)
Other versions
EP0327519A1 (en
Inventor
Anders Tore Kers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astra AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra AB filed Critical Astra AB
Priority to AT89850025T priority Critical patent/ATE68957T1/en
Publication of EP0327519A1 publication Critical patent/EP0327519A1/en
Application granted granted Critical
Publication of EP0327519B1 publication Critical patent/EP0327519B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2089Containers or vials which are to be joined to each other in order to mix their contents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2096Combination of a vial and a syringe for transferring or mixing their contents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2006Piercing means
    • A61J1/201Piercing means having one piercing end
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2048Connecting means
    • A61J1/2055Connecting means having gripping means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2048Connecting means
    • A61J1/2058Connecting means having multiple connecting ports

Definitions

  • This invention relates to an appliance for the mixing and/or transfer of a substance, in particular a medical solution.
  • the appliance comprises a first unit, provided with one or more connection apertures for connection to an external container, and a second unit connected to, or connectable to, a container for the substance.
  • Devices are fitted to the first and second units for connection of both units to each other.
  • Certain medical preparations used in the medical care area expose both personnel and patients to considerable risks when the preparations are handled. This applies primarily to cytostatic or cytotoxic drugs which are used to treat cancer patients, but also other substances such as antibiotics which when handled can give negative reactions in personnel and patients due to the allergenic properties of the preparation. An increased awareness of personnel and hospital management of these risks has resulted in systems which will reduce the risk in the handling of these preparations.
  • Sterile medicaments intended for injection or infusion are normally supplied in powder form in glas bottles with tight-fitting seals.
  • the powder is to be mixed with a liquid, such as sterile water, saline solution or some other solution.
  • a liquid such as sterile water, saline solution or some other solution.
  • This liquid is preferably supplied in a glass ampoule, and mixing of the liquid and powder takes place by means of the liquid in the glass ampoule first being drawn into a hypodermic syringe, after which the liquid is injected into the glass bottle by the syringe penetrating the seal of the glass bottle. The bottle is shaken so that the powder and liquid mix, after which the mixture is drawn back into the hypodermic syringe.
  • the published Swedish Patent SE-B-434700 discloses such a disposable appliance, intended for the prevention of air contamination in the transfer of a substance from a vessel to a hypodermic syringe.
  • the appliance comprises a first part, in which a needle is enclosed and which is also fitted with a membrane that can be pierced by the needle, as well as with a connection aperture, in which a bung to a hypodermic syringe is intended to be connected.
  • the appliance comprises a second part, which is also fitted with a penetrable membrane.
  • the first and second parts are detachably connectable to each other, whereby both membranes in the connected position bear on each other.
  • the second part is designed so that it can be snapped onto a sealed bottle containing the dry substance.
  • the needle When the first part is compressed, which is possible by virtue of it having flexible side walls, the needle penetrates both membranes as well as the seal of the bottle so that a protected connection is formed between the syringe and the bottle. Mixing and transfer take place through the liquid being drawn into a syringe which is thereafter connected to the connection aperture of the first part. The liquid is pressed down into the bottle and is mixed with the powder, after which the solution formed is drawn back into the syringe.
  • WO 85/04097 Another design of a disposable type is disclosed in WO 85/04097.
  • This application shows an appliance where the bottle containing the dry substance is enclosed in a larger, flexible, surrounding and sealed container.
  • the hollow needle of a hypodermic syringe penetrates the container and bottle seals, and liquid is injected into the bottle from the syringe, at which positive pressure forms in the bottle.
  • the positive pressure in the bottle is equalized by permitting the gas to escape into the surrounding container.
  • the container can be fitted with a multi-channel valve, which is adjustable by turning the body of the valve manually. The different positions of the valve body open and close connections between the various connections in the valve seat.
  • connections are intended for the connection of a hypodermic syringe as well as various tubes that are attached to external appliances.
  • a hollow needle connected to the central aperture of the valve body penetrates the seal of the bottle, whereby a connection between the bottle and the valve seat arises.
  • a major disadvantage of the systems described above is that they are complicated to use, and for safe and proper handling require a large number of actions. The risk of an erroneous action thus increases, which results in decreased safety in the system.
  • Another disadvantage is that both systems are complicated and have a great number of details in their structural design, which gives a high production cost which is especially troublesome for medical care equipment intended for single use.
  • the components of the known systems are difficult to keep sterile during handling. Patients who are treated with cytostatic substances often have poor immune defence, which is why extra-high requirements concerning sterility are imposed on products that are to be used in this context.
  • the aim of this invention is to solve the above-mentioned problems by means of a system which contains a small number of simply-formed parts, a system which can be handled in one single operation and which is adapted for connection to standard accessories.
  • the present invention is characterized by the fact that an automatic shut-off valve is incorporated in at least one connection aperture in the first unit. In an inactive position, this valve keeps the connection aperture closed, and is opened, and kept open by, a container connected in the connection aperture.
  • the design according to the invention meets the essential requirements that are made on a well-functioning and safe system for the mixing and transfer of a medical substance, e.g. cytostatics, viz:
  • the present invention creates the possibility of decentralizing the handling of pharmaceutical substances from the central medical care institutions to the local medical care units. Decentralization of this type leads to major benefits for both patients and medical care administrations.
  • the present invention is principally intended for the mixing of a substance in powder form with a liquid in order to form a solution which is transferred to a hypodermic syringe.
  • the appliance can also be used for mixing two or more liquids or gases and for only transferring a liquid or gas to an external container.
  • the connection apertures that shall not be used are in such cases sealed, preferably with a plug that is specially adapted to, and seals, such apertures.
  • All connections incorporated in the appliance such as shut-off valves, external container connections, bottle seals and devices for connection of the first and second units to each other, are designed so that they seal off gas at a certain positive or negative pressure, which in certain cases occurs in the drying or mixing process. Furthermore, positive pressure can be created by protective gas (nitrogen) being added to the container holding the ready-mixed solution, with the aim of making it possible to store the solution during a shorter period of time.
  • protective gas nitrogen
  • the appliance according to the present invention consists of a first unit which comprises a mixing unit (2) and a second unit which comprises a sealing unit (4) to a substance container (6), particularly a glass bottle, which contains a freeze-dried medical product, e.g. cytostatic.
  • a valve plug (52) is fitted at one end of the mixing unit, and is designed to create a shut-off valve (8) to a first connection aperture (10) intended for the connection of a hypodermic syringe (12).
  • a second connection aperture (14) is provided on the mixing unit for connection of a flexible liquid container (16), e.g. Polyamp R .
  • Figures 2a and 2b show the sealing unit (4) in two different positions on the glass bottle (6).
  • the seal is in a first stop position on the glass bottle where the flange (18) of the bottle is kept in place between four upper and four lower lips (20) on the inside of the lower part of the sealing unit.
  • the cytostatic in the glass bottle can be freeze dried in a traditional process in which steam passes through a number of slits (22) in the lower part of the seal.
  • the sealing unit is depressed to the position shown in Figure 2b, whereby the sealing ring (24) fits tightly against the upper edge of the glass bottle (6) and the upper lips (20) fit in beneath the flange (18) of the glass bottle.
  • a locking ring (26) is pressed past the projection (28) to the final locking position which is shown in Figure 2b.
  • the glass bottle (6) is now safely sealed in that the flange (18) is locked by the upper lips (20) which are secured in position by the locking ring (26), which in turn is secured by the projection (28).
  • the sealing unit (4) also has a predominantly cylindrical neck (30) provided with two external bayonet lips (32) for interaction with thread-shaped grooves in the mixing unit (2).
  • the base of a cylindrical aperture (34) is designed with an internal penetrable membrane (36) and this aperture is kept sterile before use in that the connection unit (4) is covered by either a removable, welded wafer (38) made of aluminium, plastic laminate or some other suitable material or an injection moulded cap. Unlike earlier mechanical seals, the welded seal on the wafer (38) guarantees a sterile aperture for connection to the mixing unit (2).
  • the connection unit is made of a suitable plastic material, preferably polypropylene.
  • the mixing unit (2) which is shown in Figure 3, is made of a transparent plastic material such as polycarbonate, which makes it possible for the user to check that the system is air-tight and that virtually complete emptying of the appliance has taken place. Before use the mixing unit is preferably sterile packed in a blisterpack.
  • the mixing unit (2) consists of a lower section in the form of a cylindrical housing (40), in which internal thread-shaped grooves (42) are designed for interaction with the bayonet lips (32) of the connection unit.
  • the thread-shaped grooves may be designed with wedge-shaped steps (not shown) for locking of the bayonet lips (32) in the threaded position.
  • the spike may also be fitted with an external sealing lip (not shown in the figures).
  • the tube-shaped spike (44) is combined with a duct (48) which passes through the mixing unit (2) and widens in the section for the first connection aperture.
  • a valve plug (52) is pressed in to form a sealed contact against the walls of the widened duct.
  • the valve plug (52) should preferably be provided with sealing grooves (54) to guarantee a complete seal.
  • the material used for the plug consists of a medically adapted rubber material which shall be sealed against migration and be hygienic.
  • the external section (56) of the valve plug is solid, and the inner part changes into the shape of a cylindrical tube (58).
  • an aperture (60) is provided in the cylinder wall.
  • a first connection aperture (10) is provided in the mixing unit, which opens into the widened duct (50) in the immediate vicinity of the valve aperture (60).
  • the mouth of the connection (10) is in a first position closed by a valve tongue (62), and in a second position, which is shown in Figure 1, open in that the valve tongue (62) is bent to one side.
  • the connection aperture (10) is slightly conical in order to be able to be connected in a sealed manner to the Luer cone (64) of a hypodermic syringe (12) (see Figure 1).
  • the outer point of the Luer cone (64) penetrates to a certain extent into the widened duct (50) when the Luer cone is fully inserted into the connection aperture (10).
  • the valve tongue (62) below the valve aperture (60) is thereby bent to one side so that a connection is made between the duct (48) of the mixing unit and the first connection aperture (10), and thus the hypodermic syringe.
  • the connection aperture is externally provided with two opposing locking lips (66), referred to as a Luer lock.
  • the locking lips are intended to interact with corresponding grooves in the hypodermic syringe for axial locking of the syringe in the inserted position.
  • the mixing unit (2) is also provided with a second connection aperture (14) which opens into the duct (48) and which externally has the shape of a Luer cone.
  • the second connection aperture (14) is intended for connection to a flexible liquid container (16) (see Figure 1), e.g. Polyamp R with a female Luer aperture.
  • a flexible liquid container (16) see Figure 1
  • two gripping devices (68) are provided, which grasp the opening edge of the liquid container (16) (see Figure 1).
  • Figure 5 shows how gripping tongues (70) on each side of the connection apertures (10, 14) grip them so that the tongues (70) constitute grip protection for these apertures and thereby prevent contamination during handling.
  • FIG. 6a and 6b An alternative design of the mixing unit (2) is shown in Figures 6a and 6b.
  • the mixing unit (2) is designed with the first (10) and the second connection apertures (14) arranged opposite each other at the same level and connected to each other by a through duct.
  • a valve plug (52) is fitted and designed largely as in Figure 4 with the exception of a further recess (82) in the cylindrical tube part (58), which connects the duct (48) with the inner section of the valve plug.
  • a tube-shaped spike (44) is connected to the centre of the duct and is surrounded by a cylindrical housing (40) in the same way as shown in Figures 1 and 3. Gripping tongues (70) protect the two connection apertures (10, 14) against touch.
  • valve plug (52) is designed as an upwardly open cylindrical container with a rounded bottom, the external contours of which seal and bear against the inner walls of the widened duct (50).
  • a tensioning device (72) is provided to press the cylinder walls against the walls of the duct in this part of the plug.
  • the mixing unit (2) which is shown in Figures 8a and 8b is designed with the first and second connection apertures (10, 14) arranged in the main opposite each other.
  • a homogeneous valve plug (52) is pressed into the widened duct (50).
  • the inner part of the plug (52) has a rounded form which connects to the shape of the widened duct (50) (see Figure 8b).
  • a groove (74) is provided, which runs from the first connection aperture (10) via the duct (48) and to the second connection aperture (14).
  • a corresponding lip (76) against the groove (74) is provided in the widened duct (50) between the first connection aperture (10) and the duct (48).
  • the groove (74) thus creates an open connection between the duct (48) and the second connection aperture (14), whilst the lip (76) seals and bears against the groove (74) between the duct (48) and the first connection aperture (10), so that no connection between the duct (48) and the aperture (10) exists.
  • the Luer cone (64) presses against the homogeneous valve plug (52), so that groove (74) and lip (76) separate and a connection is formed.
  • FIG. 9 shows a further alternative design of the valve plug (52), which here is provided with a closure bung (78, 80) adapted for each connection aperture (10, 14).
  • the second open (in a normal position) connection aperture (14) is closed by the closure bung (78) when the Luer cone (64) of the syringe on connection opens the first connection aperture (10) by means of pressing the corresponding closure bung (80) out of the aperture.
  • the wafer (38) is first removed from the sealing unit of the glass bottle (4), so that the cylindrical aperture (34) is exposed.
  • the mixing unit (2) is taken out of the blisterpack with the help of grip tongues (70), which protect the connection apertures (10, 14) against touch.
  • the flexible liquid container (Polyamp R ) (16) is thereafter opened and connected to the Luer cone at the second connection aperture (14) on the mixing unit (2), at which the gripping device (68) grips the edge of the opening on the liquid container (16) and locks it to the mixing unit (2).
  • the sealing unit (4) is threaded onto the mixing unit (2), whereby the spike (44) enters the cylindrical aperture (34) of the sealing unit so that a sealing connection is formed between the parts before the point (46) of the spike penetrates the membrane (36).
  • the sealing unit (4) and the mixing unit (2) are thoroughly screwed and possibly locked to each other, the liquid in the flexible liquid container (16) is pumped down into the glass bottle (6), where it is mixed with the powdery substance into a solution by means of the bottle being shaken.
  • the hypodermic syringe (12) is thereafter connected by means of the Luer cone (64) of the syringe entering the first connection aperture (10) and the syring being screwed fast to the external locking lips (66) of the connection.
  • the outer end of the Luer cone in this position presses down the sealing valve tongue (62), so that a connection between the duct (48) and the syringe (12) is formed.
  • valve plug (52) is designed so that when the syringe (12) is connected, and thus the first connection aperture (10) is open, the second connection aperture (14) is closed.
  • the ready-mixed solution is therefore drawn from the glass bottle (6) directly into the hypodermic syringe (12).
  • the valve plug may have a cross section of various geometric forms such as circular, square, rectangual or oval.
  • the number of connection apertures may vary from one upwards, according to the need to connect different containers.
  • the sealing unit may instead be designed to be pressed onto the sealed glass bottle when the mixing process is to begin.
  • a sealing lip may be provided in the cylindrical aperture instead of on the needle.
  • the conical needle may instead be cylindrical, in which case the interacting opening in the sealing unit shall also have a corresponding cylindrical form.
  • the substance container may consist of a plastic bottle, in which case the locking ring may be replaced by a sealing weld joint between the sealing unit and the plastic bottle.

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nozzles (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)

Abstract

An appliance for the mixing and/or transfer of a substance, particularly a medical solution. The appliance comprises a first unit (2), with one or more connection apertures (10, 14) for connection to external containers (12, 16) and a second unit(4) which is connected or connectable to a substance container (6). Devices (44, 34) are provided on said first and second units (2, 4) for connection of the two units to each other. An automatic shut-off valve (8) is fitted in at least one of the connection apertures in the first unit (2). The valve (8) keeps the connection aperture (10) closed in an inactive position, whilst it is opened and kept open by the container (12) connected to one of the connection apertures (10.

Description

    Technical field
  • This invention relates to an appliance for the mixing and/or transfer of a substance, in particular a medical solution. The appliance comprises a first unit, provided with one or more connection apertures for connection to an external container, and a second unit connected to, or connectable to, a container for the substance. Devices are fitted to the first and second units for connection of both units to each other.
  • Background art
  • Certain medical preparations used in the medical care area expose both personnel and patients to considerable risks when the preparations are handled. This applies primarily to cytostatic or cytotoxic drugs which are used to treat cancer patients, but also other substances such as antibiotics which when handled can give negative reactions in personnel and patients due to the allergenic properties of the preparation. An increased awareness of personnel and hospital management of these risks has resulted in systems which will reduce the risk in the handling of these preparations.
  • Sterile medicaments intended for injection or infusion, e.g. cytostatic, are normally supplied in powder form in glas bottles with tight-fitting seals. When used, the powder is to be mixed with a liquid, such as sterile water, saline solution or some other solution. This liquid is preferably supplied in a glass ampoule, and mixing of the liquid and powder takes place by means of the liquid in the glass ampoule first being drawn into a hypodermic syringe, after which the liquid is injected into the glass bottle by the syringe penetrating the seal of the glass bottle. The bottle is shaken so that the powder and liquid mix, after which the mixture is drawn back into the hypodermic syringe. Unless additional safety precautions are taken, such handling entails major risks for the personnel involved. Spillage in the form of drippings and drops is difficult to avoid, at the same time as contamination of the surrounding air occurs through the formation of positive pressure in the glass bottle which leads to the leakage of aerosol mist to the surroundings.
  • Personnel who treat patients with cytostatic and other toxic substances are exposed to the risk of inhaling, or otherwise being affected by direct contact with, these substances. The increased awareness of these risks has resulted in that the handling of these substances, i.e. the mixing of powder and liquid, and the filling of hypodermic syringes, today takes place in special hoods. Handling in these hoods is complicated and inconvenient for the personnel. In addition it necessitates the centralized treatment of patients, since such expensive equipment can only be justified in central medical care units.
  • In order to overcome the problems described above, systems of a disposable type have been designed for the mixing and transfer of medical preparations.
  • The published Swedish Patent SE-B-434700 discloses such a disposable appliance, intended for the prevention of air contamination in the transfer of a substance from a vessel to a hypodermic syringe. The appliance comprises a first part, in which a needle is enclosed and which is also fitted with a membrane that can be pierced by the needle, as well as with a connection aperture, in which a bung to a hypodermic syringe is intended to be connected. Further, the appliance comprises a second part, which is also fitted with a penetrable membrane. The first and second parts are detachably connectable to each other, whereby both membranes in the connected position bear on each other. The second part is designed so that it can be snapped onto a sealed bottle containing the dry substance. When the first part is compressed, which is possible by virtue of it having flexible side walls, the needle penetrates both membranes as well as the seal of the bottle so that a protected connection is formed between the syringe and the bottle. Mixing and transfer take place through the liquid being drawn into a syringe which is thereafter connected to the connection aperture of the first part. The liquid is pressed down into the bottle and is mixed with the powder, after which the solution formed is drawn back into the syringe.
  • Another design of a disposable type is disclosed in WO 85/04097. This application shows an appliance where the bottle containing the dry substance is enclosed in a larger, flexible, surrounding and sealed container. The hollow needle of a hypodermic syringe penetrates the container and bottle seals, and liquid is injected into the bottle from the syringe, at which positive pressure forms in the bottle. The positive pressure in the bottle is equalized by permitting the gas to escape into the surrounding container. Instead of a normal penetrable seal, the container can be fitted with a multi-channel valve, which is adjustable by turning the body of the valve manually. The different positions of the valve body open and close connections between the various connections in the valve seat. These connections are intended for the connection of a hypodermic syringe as well as various tubes that are attached to external appliances. A hollow needle connected to the central aperture of the valve body penetrates the seal of the bottle, whereby a connection between the bottle and the valve seat arises.
  • A further example of apparatus for aseptic liquid transfer is disclosed in US-A-2954769.
  • A major disadvantage of the systems described above is that they are complicated to use, and for safe and proper handling require a large number of actions. The risk of an erroneous action thus increases, which results in decreased safety in the system. Another disadvantage is that both systems are complicated and have a great number of details in their structural design, which gives a high production cost which is especially troublesome for medical care equipment intended for single use. The components of the known systems are difficult to keep sterile during handling. Patients who are treated with cytostatic substances often have poor immune defence, which is why extra-high requirements concerning sterility are imposed on products that are to be used in this context.
  • Basic idea of the invention
  • The aim of this invention is to solve the above-mentioned problems by means of a system which contains a small number of simply-formed parts, a system which can be handled in one single operation and which is adapted for connection to standard accessories.
  • The present invention is characterized by the fact that an automatic shut-off valve is incorporated in at least one connection aperture in the first unit. In an inactive position, this valve keeps the connection aperture closed, and is opened, and kept open by, a container connected in the connection aperture.
  • Further advantageous characteristics are apparent from the following description of the working example and by dependent claims.
  • The design according to the invention meets the essential requirements that are made on a well-functioning and safe system for the mixing and transfer of a medical substance, e.g. cytostatics, viz:
  • a)
    The system shall be sealed, no leakage shall be able to occur.
    b)
    The system shall be inexpensive so that it is suitable for disposable use, even for medical products less expensive than cytostatic drugs, such as antibiotics, anaesthetics etc.
    c)
    The use of the system shall be simple and uncomplicated, and the risk of erroneous action minimized.
    d)
    Emptying of the system shall be almost total, owing to the fact that cytostatics are a comparatively expensive product.
    e)
    Incorporated units shall be able to be kept sterile in handling.
    f)
    Standardized accessories shall be simple and be able to be connected safely to the system.

  • The present invention creates the possibility of decentralizing the handling of pharmaceutical substances from the central medical care institutions to the local medical care units. Decentralization of this type leads to major benefits for both patients and medical care administrations.
  • The present invention is principally intended for the mixing of a substance in powder form with a liquid in order to form a solution which is transferred to a hypodermic syringe. However, the appliance can also be used for mixing two or more liquids or gases and for only transferring a liquid or gas to an external container. The connection apertures that shall not be used are in such cases sealed, preferably with a plug that is specially adapted to, and seals, such apertures.
  • All connections incorporated in the appliance, such as shut-off valves, external container connections, bottle seals and devices for connection of the first and second units to each other, are designed so that they seal off gas at a certain positive or negative pressure, which in certain cases occurs in the drying or mixing process. Furthermore, positive pressure can be created by protective gas (nitrogen) being added to the container holding the ready-mixed solution, with the aim of making it possible to store the solution during a shorter period of time.
  • Brief description of appended drawings
  • An embodiment of the present invention, and modification of the same, are described in closer detail below, with reference to appended drawings, where
    • ― Figure 1 shows an axial section through one embodiment of the invention in a position where the first and second units are connected to eath other
    • ― Figure 2 a-b show an axial section through the second unit, or sealing unit, in two different positions on the mouth of the substance container
    • ― Figure 3 shows an axial section through the first unit, or mixing unit
    • ― Figure 4 shows an enlarged section along line IV-IV in Figure 1
    • ― Figure 5 shows the appliance as per Figure 1 seen from above and enlarged
    • ― Figure 6a and 6b show an axial cross section view and side view of an alternative design of the first unit, or mixing unit
    • ― Figure 7 shows an axial section through a second embodiment of the valve plug in the mixing unit
    • ― Figure 8a shows an axial section through a third embodiment of the valve plug in the mixing unit, and Figure 8b shows a section along line VIIIb-VIIb in Figure 8a
    • ― Figure 9 shows an axial section through a fourth embodiment of the valve plug
    • ― Figure 10 shows the appliance as per Figure 1 in use
    Detailed description of presented embodiments of the invention
  • From Figure 1 it can be seen that the appliance according to the present invention consists of a first unit which comprises a mixing unit (2) and a second unit which comprises a sealing unit (4) to a substance container (6), particularly a glass bottle, which contains a freeze-dried medical product, e.g. cytostatic. A valve plug (52) is fitted at one end of the mixing unit, and is designed to create a shut-off valve (8) to a first connection aperture (10) intended for the connection of a hypodermic syringe (12). A second connection aperture (14) is provided on the mixing unit for connection of a flexible liquid container (16), e.g. PolyampR.
  • Figures 2a and 2b show the sealing unit (4) in two different positions on the glass bottle (6). In Figure 2a, the seal is in a first stop position on the glass bottle where the flange (18) of the bottle is kept in place between four upper and four lower lips (20) on the inside of the lower part of the sealing unit. In this closing position, the cytostatic in the glass bottle can be freeze dried in a traditional process in which steam passes through a number of slits (22) in the lower part of the seal. On completion of drying, the sealing unit is depressed to the position shown in Figure 2b, whereby the sealing ring (24) fits tightly against the upper edge of the glass bottle (6) and the upper lips (20) fit in beneath the flange (18) of the glass bottle. A locking ring (26) is pressed past the projection (28) to the final locking position which is shown in Figure 2b. The glass bottle (6) is now safely sealed in that the flange (18) is locked by the upper lips (20) which are secured in position by the locking ring (26), which in turn is secured by the projection (28).
  • The sealing unit (4) also has a predominantly cylindrical neck (30) provided with two external bayonet lips (32) for interaction with thread-shaped grooves in the mixing unit (2). The base of a cylindrical aperture (34) is designed with an internal penetrable membrane (36) and this aperture is kept sterile before use in that the connection unit (4) is covered by either a removable, welded wafer (38) made of aluminium, plastic laminate or some other suitable material or an injection moulded cap. Unlike earlier mechanical seals, the welded seal on the wafer (38) guarantees a sterile aperture for connection to the mixing unit (2). The connection unit is made of a suitable plastic material, preferably polypropylene.
  • The mixing unit (2), which is shown in Figure 3, is made of a transparent plastic material such as polycarbonate, which makes it possible for the user to check that the system is air-tight and that virtually complete emptying of the appliance has taken place. Before use the mixing unit is preferably sterile packed in a blisterpack.
  • The mixing unit (2) consists of a lower section in the form of a cylindrical housing (40), in which internal thread-shaped grooves (42) are designed for interaction with the bayonet lips (32) of the connection unit. The thread-shaped grooves may be designed with wedge-shaped steps (not shown) for locking of the bayonet lips (32) in the threaded position. Inside the housing (40) and protected by it from movement, there is a centrally-located open, tube-shaped spike (44), which is cut diagonally so that a point (46) or a conically shaped tip is formed at the external end. The spike may also be fitted with an external sealing lip (not shown in the figures). The tube-shaped spike (44) is combined with a duct (48) which passes through the mixing unit (2) and widens in the section for the first connection aperture. In the widened section (50), a valve plug (52) is pressed in to form a sealed contact against the walls of the widened duct. The valve plug (52) should preferably be provided with sealing grooves (54) to guarantee a complete seal. The material used for the plug consists of a medically adapted rubber material which shall be sealed against migration and be hygienic. The external section (56) of the valve plug is solid, and the inner part changes into the shape of a cylindrical tube (58). At the connection between the two parts, an aperture (60) (see also Figure 4) is provided in the cylinder wall.
  • A first connection aperture (10) is provided in the mixing unit, which opens into the widened duct (50) in the immediate vicinity of the valve aperture (60). The mouth of the connection (10) is in a first position closed by a valve tongue (62), and in a second position, which is shown in Figure 1, open in that the valve tongue (62) is bent to one side. The connection aperture (10) is slightly conical in order to be able to be connected in a sealed manner to the Luer cone (64) of a hypodermic syringe (12) (see Figure 1). The outer point of the Luer cone (64) penetrates to a certain extent into the widened duct (50) when the Luer cone is fully inserted into the connection aperture (10). The valve tongue (62) below the valve aperture (60) is thereby bent to one side so that a connection is made between the duct (48) of the mixing unit and the first connection aperture (10), and thus the hypodermic syringe. The connection aperture is externally provided with two opposing locking lips (66), referred to as a Luer lock. The locking lips are intended to interact with corresponding grooves in the hypodermic syringe for axial locking of the syringe in the inserted position.
  • The mixing unit (2) is also provided with a second connection aperture (14) which opens into the duct (48) and which externally has the shape of a Luer cone. The second connection aperture (14) is intended for connection to a flexible liquid container (16) (see Figure 1), e.g. PolyampR with a female Luer aperture. In order to lock the liquid container (16) axially in a connected position, two gripping devices (68) are provided, which grasp the opening edge of the liquid container (16) (see Figure 1). Figure 5 shows how gripping tongues (70) on each side of the connection apertures (10, 14) grip them so that the tongues (70) constitute grip protection for these apertures and thereby prevent contamination during handling.
  • An alternative design of the mixing unit (2) is shown in Figures 6a and 6b. Here the mixing unit (2) is designed with the first (10) and the second connection apertures (14) arranged opposite each other at the same level and connected to each other by a through duct. A valve plug (52) is fitted and designed largely as in Figure 4 with the exception of a further recess (82) in the cylindrical tube part (58), which connects the duct (48) with the inner section of the valve plug. A tube-shaped spike (44) is connected to the centre of the duct and is surrounded by a cylindrical housing (40) in the same way as shown in Figures 1 and 3. Gripping tongues (70) protect the two connection apertures (10, 14) against touch.
  • An alternative design of the valve plug is shown in Figure 7. Here the valve plug (52) is designed as an upwardly open cylindrical container with a rounded bottom, the external contours of which seal and bear against the inner walls of the widened duct (50). In order to ensure a complete seal in the outer part of the plug, a tensioning device (72) is provided to press the cylinder walls against the walls of the duct in this part of the plug. When a Luer cone (64) (see Figure 1) is connected to the first connection aperture (10), the elastic wall is pressed in so that a connection with the duct (48) is opened on the outside of the valve plug (52).
  • The mixing unit (2) which is shown in Figures 8a and 8b is designed with the first and second connection apertures (10, 14) arranged in the main opposite each other. A homogeneous valve plug (52) is pressed into the widened duct (50). The inner part of the plug (52) has a rounded form which connects to the shape of the widened duct (50) (see Figure 8b). In this part of the valve plug a groove (74) is provided, which runs from the first connection aperture (10) via the duct (48) and to the second connection aperture (14). A corresponding lip (76) against the groove (74) is provided in the widened duct (50) between the first connection aperture (10) and the duct (48). The groove (74) thus creates an open connection between the duct (48) and the second connection aperture (14), whilst the lip (76) seals and bears against the groove (74) between the duct (48) and the first connection aperture (10), so that no connection between the duct (48) and the aperture (10) exists. When the syringe (12) is connected (see Figure 1), the Luer cone (64) presses against the homogeneous valve plug (52), so that groove (74) and lip (76) separate and a connection is formed.
  • Figure 9 shows a further alternative design of the valve plug (52), which here is provided with a closure bung (78, 80) adapted for each connection aperture (10, 14). The second open (in a normal position) connection aperture (14) is closed by the closure bung (78) when the Luer cone (64) of the syringe on connection opens the first connection aperture (10) by means of pressing the corresponding closure bung (80) out of the aperture.
  • Function of the invention
  • When the mixing system according to the present invention is to be used, see Figure 1, the wafer (38) is first removed from the sealing unit of the glass bottle (4), so that the cylindrical aperture (34) is exposed. The mixing unit (2) is taken out of the blisterpack with the help of grip tongues (70), which protect the connection apertures (10, 14) against touch. The flexible liquid container (PolyampR) (16) is thereafter opened and connected to the Luer cone at the second connection aperture (14) on the mixing unit (2), at which the gripping device (68) grips the edge of the opening on the liquid container (16) and locks it to the mixing unit (2). The sealing unit (4) is threaded onto the mixing unit (2), whereby the spike (44) enters the cylindrical aperture (34) of the sealing unit so that a sealing connection is formed between the parts before the point (46) of the spike penetrates the membrane (36).
  • When the sealing unit (4) and the mixing unit (2) are thoroughly screwed and possibly locked to each other, the liquid in the flexible liquid container (16) is pumped down into the glass bottle (6), where it is mixed with the powdery substance into a solution by means of the bottle being shaken.
  • The hypodermic syringe (12) is thereafter connected by means of the Luer cone (64) of the syringe entering the first connection aperture (10) and the syring being screwed fast to the external locking lips (66) of the connection. The outer end of the Luer cone in this position presses down the sealing valve tongue (62), so that a connection between the duct (48) and the syringe (12) is formed.
  • The entire assembled units is thereafter turned upside down to a position shown in Figure 10. In this position air is pumped out of the air-filled flexibel container (16), so that air flows up into the glass bottle (6), whereby a corresponding volume of the ready-mixed solution is pressed back to the flexible container (16). When there is approximately the same amount of liquid in the container (16) and the glass bottle (6), the inclination of the appliance is adjusted so that both liquid levels are the same. The solution can now be more or less completely drawn up into the hypodermic syringe (12), which can be checked through the transparent mixing unit (2).
  • When the syringe (12) is filled with solution and the mixing unit is thus empty, the syringe is screwed off the locking lips, whereby the valve tongue (62) in the mixing unit (2) again seals the connection aperture (10). The syringe can now be used for injection in a traditional way and the remaining assembled unit be destroyed at one go.
  • The best mode of carrying out the invention known at present is as described above.
  • In the case of an embodiment according to Figure 9, the function is somewhat different, since the valve plug (52) is designed so that when the syringe (12) is connected, and thus the first connection aperture (10) is open, the second connection aperture (14) is closed. The ready-mixed solution is therefore drawn from the glass bottle (6) directly into the hypodermic syringe (12).
  • Conceivable modifications of the invention
  • The invention is in no way restricted to the working examples described above, and several conceivable modifications are possible within the framework of the claims. The valve plug, for example, may have a cross section of various geometric forms such as circular, square, rectangual or oval. The number of connection apertures may vary from one upwards, according to the need to connect different containers. The sealing unit may instead be designed to be pressed onto the sealed glass bottle when the mixing process is to begin. A sealing lip may be provided in the cylindrical aperture instead of on the needle. The conical needle may instead be cylindrical, in which case the interacting opening in the sealing unit shall also have a corresponding cylindrical form. The substance container may consist of a plastic bottle, in which case the locking ring may be replaced by a sealing weld joint between the sealing unit and the plastic bottle.

Claims (10)

1. An appliance for the mixture and/or transfer of a substance, particularly a medical solution for injection, comprising a first unit (2) with one or more connection apertures (10, 14) for connection to external containers (12, 16), a second unit (4) connected or connectable to a substance container (6), whereby devices (44, 34) are provided on said first and second units (2, 4) for connection of the two units to each other, characterized in that in at least one connection aperture (10) in the first unit (2) an automatic shut-off valve (8) is fitted, which in an inactive position keeps the connection aperture (10) closed and which is opened and kept open by one (12) of the external containers inserted into the connection aperture (10).
2. An appliance as claimed in claim 1, characterized in that a shut-off valve (8) consists of an elastic plug (52) fitted in one end of a through duct (48) in the first unit (2), whereby the sealing plug (52) bears against and closes off the connection aperture (10).
3. An appliance as claimed in claim 2, characterized in that on the external container (12), preferably a hypodermic syringe, intended for connection to the connection aperture (10), a sealing Luer cone (64) is provided, whereby the point of said Luer cone, in connected position, presses down the elastic valve plug (52) to a position which opens a connection between the connection aperture (10) and the duct (48).
4. An appliance as claimed in claim 2, characterized in that said device (44) on the first unit (2), for connection to the second unit (4), contains an hollow spike (44) connected to the duct (48), the end of which spike is diagonally cut to form a point (46) or a sharp tip.
5. An appliance as claimed in claim 4, characterized in that said device (34) on the second unit (4) for connection to the first unit (2) contains cylindrical aperture (34) sealing against the spike (44), which aperture is sealed by a membrane (36) provided at the bottom of the aperture and, on connection, penetrable by the spike (44).
6. An appliance as claimed in claim 5, characterized in that means are provided to lock axially the first unit (2) to the second unit (4), whereby said means of the first unit (2) comprise a cylindrical housing (40) which surrounds the spike (44) and which is provided with internal thread-shaped grooves (42).
7. An appliance as claimed in claim 6, characterized in that the said means on the second unit (4) for axial locking to the first unit (2) comprise a cylindrical neck (30) which surrounds the cylindrical aperture (34) and which has an external diameter which is the same size as the internal diameter of the cylindrical housing (40) of the first unit, whereby two diametrically arranged, thread-shaped bayonet lips (32) are provided on the outside of the cylindrical neck (30) for interaction with the thread-shaped grooves (42) on the first unit (2).
8. An appliance as claimed in claim 7, characterized in that the cylindrical neck (30) before the connection to the first unit (2) is sealed by an aluminium wafer (38) welded fast on the neck (30).
9. An appliance as claimed in claim 2, characterized in that a second connection aperture (14) is arranged in contact with the duct (48) in the first unit (2), which aperture (14) is in the form of a Luer cone and is intended to be connected to a flexible container (16), preferably a liquid container.
10. An appliance as claimed in claim 9, characterized in that locking devices (66, 68) are provided on the connection apertures (10, 14) for axial locking of the connected containers (12, 16).
EP19890850025 1988-02-03 1989-01-30 An appliance for the mixing and/or transfer of a substance Expired - Lifetime EP0327519B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT89850025T ATE68957T1 (en) 1988-02-03 1989-01-30 DEVICE FOR CONVEYING AND/OR MIXING A SUBSTANCE.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8800337 1988-02-03
SE8800337A SE8800337L (en) 1988-02-03 1988-02-03 DEVICE FOR MIXING AND / OR TRANSFER OF A SUBSTANCE

Publications (2)

Publication Number Publication Date
EP0327519A1 EP0327519A1 (en) 1989-08-09
EP0327519B1 true EP0327519B1 (en) 1991-10-30

Family

ID=20371244

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19890850025 Expired - Lifetime EP0327519B1 (en) 1988-02-03 1989-01-30 An appliance for the mixing and/or transfer of a substance

Country Status (6)

Country Link
EP (1) EP0327519B1 (en)
AT (1) ATE68957T1 (en)
AU (1) AU2893289A (en)
DE (1) DE68900364D1 (en)
DK (1) DK32889A (en)
SE (1) SE8800337L (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021067133A1 (en) * 2019-09-30 2021-04-08 Becton, Dickinson And Company Medicament filling system

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2054366C1 (en) * 1990-11-07 1996-02-20 Оцука Фармасьютикал Фэктори, Инк. Container for isolated arrangement of liquid and powder or solid matter
US5171214A (en) * 1990-12-26 1992-12-15 Abbott Laboratories Drug storage and delivery system
GB9103291D0 (en) * 1991-02-15 1991-04-03 Waverley Pharma Ltd Transfer adaptor
GB9108655D0 (en) * 1991-04-23 1991-06-12 Waverley Pharma Ltd Improved multi-use liquid dispensers
FR2716801B1 (en) 1994-03-04 1996-09-06 Pasteur Merieux Serums Vacc Set for the distribution of a pharmaceutical solution in cartridges or the like, in particular after taking up a lyophilized product.
US5899877A (en) * 1994-04-28 1999-05-04 Primed Halberstadt Medizintechnik Gmbh One-piece dispensing device for the contamination-free administration of medicaments (cytostatica)
JP3306796B2 (en) * 1995-01-26 2002-07-24 大成化工株式会社 Glass cartridge for injection cylinder pre-filled with chemical solution
EP1277490B1 (en) * 2001-07-17 2006-06-21 Codan Holding GmbH Spike connector
EP1656214B1 (en) * 2003-08-21 2010-02-24 Medmix Systems AG Device and method for transferring, mixing and delivering components
FR2876919B1 (en) * 2004-10-26 2007-07-27 Millipore Corp HOLDING NEEDLE HAVING GAME OF GRIPPING.
EP2043504A1 (en) * 2006-07-13 2009-04-08 Novo Nordisk A/S A drug mixing and infusion device
BRPI0714879A2 (en) * 2006-07-21 2013-02-26 Polimoom Medical Packaging As Connector device and Sterile Mixing Method
US8034044B2 (en) 2008-04-04 2011-10-11 B. Braun Melsungen Ag Systems and methods for combining materials
EP2759284A1 (en) * 2013-01-28 2014-07-30 B. Braun Melsungen AG Overcap intended for a pharmaceutical container
WO2015100169A1 (en) 2013-12-27 2015-07-02 William Beaumount Hospital Container closure, container assembly and method for utilizing the same
DE202019103500U1 (en) 2019-06-25 2020-10-06 Codan Holding Gmbh Spike

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2954769A (en) * 1958-08-20 1960-10-04 American Cyanamid Co Aseptic liquid transfer apparatus
BE794915A (en) * 1972-02-03 1973-08-02 Inge Spa CLOSING DEVICE FOR BOTTLES AND ANALOGUES, ALLOWING SEPARATE STORAGE OF INGREDIENTS TO BE MIXED AT THE TIME OF USE
AT369268B (en) * 1981-07-16 1982-12-27 Trawoeger Werner VALVE FOR SUPPLYING, CHECKING AND TAKING OUT ANY CONTAINER IN AN IMPLANTED CONTAINER
SE434700B (en) * 1983-05-20 1984-08-13 Bengt Gustavsson DEVICE FOR AIRED TRANSFER OF SUBSTANCE FROM A KERLE TO ANOTHER

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021067133A1 (en) * 2019-09-30 2021-04-08 Becton, Dickinson And Company Medicament filling system

Also Published As

Publication number Publication date
EP0327519A1 (en) 1989-08-09
DK32889A (en) 1989-08-04
DE68900364D1 (en) 1991-12-05
DK32889D0 (en) 1989-01-26
ATE68957T1 (en) 1991-11-15
AU2893289A (en) 1989-08-03
SE8800337L (en) 1989-08-04
SE8800337D0 (en) 1988-02-03

Similar Documents

Publication Publication Date Title
EP0327519B1 (en) An appliance for the mixing and/or transfer of a substance
US5533994A (en) Storage and transfer bottle designed for storing two components of a medicamental substance
US4583971A (en) Closed drug delivery system
US6499617B1 (en) Rotary seal stopper
US5902298A (en) Medicament container stopper with integral spike access means
US5817082A (en) Medicament container closure with integral spike access means
US5641010A (en) Mixing and dispensing apparatus
US5921419A (en) Universal stopper
US6997917B2 (en) Table top drug dispensing vial access adapter
US7799009B2 (en) Tabletop drug dispensing vial access adapter
US6408897B1 (en) Sealed confinement device for connecting a container and means for delivering a substance
EP1008337B1 (en) Medicament container closure with recessed integral spike access means
KR100227053B1 (en) Drug vessel and durg injection set
AU2009280391B2 (en) A pre-filled container insert for mixing two or more ingredients for use in a pharmaceutical container system
US20030231545A1 (en) Multi-component handling and delivery system
US5257986A (en) Container for the separate sterile storage of at least two substances and for mixing said substances
CA2071280A1 (en) Transfer adaptors
TWI801546B (en) Sterile flexible package with pressure compensator for the dosed reconstitution of fluid medicinal or nutritional substances to be administered to patients by infusion or injection
JPH0928764A (en) Injection container
EP1084692B1 (en) Liquid container
JPH04329955A (en) Germ-free holding/mixing apparatus for two kinds of medicines held in individually sealed container
JPH04329953A (en) Gear free holding/mixing apparatus for two kinds of medicines held in individually sealed container
GB2476037A (en) Medicament mixing containers

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE ES FR GB GR IT LI LU NL SE

17P Request for examination filed

Effective date: 19900202

17Q First examination report despatched

Effective date: 19901210

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE ES FR GB GR IT LI LU NL SE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED.

Effective date: 19911030

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 19911030

Ref country code: LI

Effective date: 19911030

Ref country code: SE

Effective date: 19911030

Ref country code: BE

Effective date: 19911030

Ref country code: NL

Effective date: 19911030

Ref country code: CH

Effective date: 19911030

Ref country code: AT

Effective date: 19911030

Ref country code: ES

Free format text: THE PATENT HAS BEEN ANNULLED BY A DECISION OF A NATIONAL AUTHORITY

Effective date: 19911030

REF Corresponds to:

Ref document number: 68957

Country of ref document: AT

Date of ref document: 19911115

Kind code of ref document: T

REF Corresponds to:

Ref document number: 68900364

Country of ref document: DE

Date of ref document: 19911205

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19920131

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

NLV1 Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act
EN Fr: translation not filed
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Effective date: 19920320

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Effective date: 19921001

26N No opposition filed
REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Effective date: 19930130

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 19930130